Company Filing History:
5 out of 541 
1 out of 3,440 
Years Active: 2001-2018
Title: **Innovator in Vaccine Development: Jose Casas-Finet**
Introduction
Jose Casas-Finet, based in Gaithersburg, MD, is a notable inventor recognized for his significant contributions to the field of medical innovations, particularly in vaccine development. He holds a total of six patents, demonstrating his commitment to advancing healthcare solutions.
Latest Patents
Among his latest patents is a groundbreaking invention focused on antibodies and methods for producing vaccines against respiratory syncytial virus (RSV). This patent details novel RSV F peptides and related compositions, highlighting methods for evaluating anti-RSV antibody binding to these peptides. The invention also provides essential protocols for the administration of F peptides and antibodies that can prevent, neutralize, and treat RSV infections. Furthermore, it aims to enhance the treatment and prevention of symptoms associated with RSV.
Career Highlights
Throughout his career, Jose has made remarkable strides in the biopharmaceutical industry. He has collaborated with prominent organizations, enhancing his research and development capabilities. One notable employer is MedImmune Limited, where he gained invaluable experience in vaccine innovation. Additionally, he has worked with The United States of America, as represented by the Secretary of the Department of Health and Human Services, contributing to public health initiatives.
Collaborations
Jose has collaborated with esteemed professionals in the industry, including Guillermo Tous and Mark Schenerman. These partnerships have not only fostered innovation but have also contributed to advancing the understanding of antibodies and their role in combating viral infections.
Conclusion
In conclusion, Jose Casas-Finet stands out as an influential inventor in the field of vaccine development, particularly through his work with respiratory syncytial virus. His patents reflect a dedication to enhancing health outcomes and preventing viral infections, and his collaborations with leading companies and experts underscore the significance of teamwork in scientific advancements.